Augmentation of hydroxyurea cytotoxicity by sintamil in human chronic myeloid leukemia cells

Tumori. 1986 Oct 31;72(5):507-10. doi: 10.1177/030089168607200510.

Abstract

The in vitro effect of sintamil, as a modulator alone and in combination with hydroxyurea (HU), on cytotoxicity was studied in 16 cases of human chronic myeloid leukemia (CML). We investigated the cytotoxicity of the drugs as a function of the exposure dose (HU, 10(-4) M; sintamil, 10 micrograms/ml) and the exposure time (1 h) to the agent. Cytotoxicity was evaluated as the inhibition of incorporation of [3H-methyl]thymidine in the nucleic acids of CML cells. Cytotoxicity of HU was greatly enhanced (P less than 0.001) by 1 h exposure of the CML cells to sintamil. The present data indicate that sintamil potentiates the cytotoxic activity of HU in CML cells.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cell Survival / drug effects
  • Dibenzoxazepines / therapeutic use*
  • Drug Interactions
  • Humans
  • Hydroxyurea / therapeutic use*
  • Leukemia, Myeloid / drug therapy*

Substances

  • Dibenzoxazepines
  • sintamil
  • Hydroxyurea